Exenatide vs Liraglutide
Both are categorized under GLP-1 agonist in our directory—here is how they differ in name, use, and label context.
Exenatide
GLP-1 agonist
The first approved GLP-1 mimetic—derived from Gila monster saliva peptide exendin-4.
Exenatide was isolated from the Gila monster and modified for human use. It lowers blood glucose and modestly reduces weight. Largely replaced by newer GLP-1 drugs but remains a reference point for the peptide drug class…
Liraglutide
GLP-1 agonist
An earlier daily-injection GLP-1 agonist—still used for diabetes and weight loss.
Liraglutide was the first GLP-1 drug widely used for obesity (Saxenda). It works similarly to semaglutide but requires daily dosing and tends to produce somewhat less weight loss. Well-studied safety profile over many pa…
Quick comparison
- Exenatide: GLP-1 agonist — The first approved GLP-1 mimetic—derived from Gila monster saliva peptide exendin-4.…
- Liraglutide: GLP-1 agonist — An earlier daily-injection GLP-1 agonist—still used for diabetes and weight loss.…